GBA Gene Lewy body dementia susceptibility to Genetic Test sale cost 3200 AED
SDHA Gene Leigh syndrome Genetic Test sale cost 4400 AED SDHA Gene Leigh syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
FKRP Gene Limb-girdle muscular dystrophy autosomal recessive type 2I Genetic Test sale cost 4400 AED FKRP Gene Limb-girdle muscular dystrophy autosomal recessive type 2I Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

GBA Gene Lewy body dementia susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

Title: GBA Gene and Lewy Body Dementia: Susceptibility Testing at DNA Labs UAE

Lewy body dementia (LBD) is a complex, progressive brain disorder characterized by the accumulation of Lewy bodies in the nerve cells, leading to cognitive decline, movement disorders, and psychiatric symptoms. Recent studies have identified a significant link between mutations in the GBA gene and an increased susceptibility to developing Lewy body dementia. The GBA gene, responsible for producing the enzyme glucocerebrosidase, plays a critical role in the brain’s cellular waste management. Mutations in this gene can lead to the accumulation of harmful substances in the brain, contributing to the development of LBD.

Recognizing the importance of genetic factors in LBD, DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the GBA gene. This test is a valuable tool for individuals with a family history of LBD or related neurodegenerative disorders, as it can help assess their risk of developing the condition. Early identification of susceptibility can be crucial in managing symptoms, planning for the future, and participating in clinical trials for novel therapies.

The testing process at DNA Labs UAE is streamlined and patient-friendly. A simple saliva or blood sample is all that’s required for the analysis. The lab utilizes state-of-the-art genetic sequencing technologies to ensure accurate and reliable results.

The cost of the GBA gene test is 3200 AED, a worthwhile investment for those seeking insight into their genetic predisposition to Lewy body dementia. This knowledge not only empowers individuals and their families but also contributes to the broader understanding of LBD, paving the way for advancements in treatment and care.

For more information or to schedule a test, individuals are encouraged to contact DNA Labs UAE directly. Their team of genetic counselors and specialists is available to provide support throughout the testing process, ensuring that clients are fully informed and comfortable with each step.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GBA Gene Lewy Body Dementia Susceptibility to Genetic Test

Welcome to DNA Labs UAE, where we offer the GBA Gene Lewy Body Dementia Susceptibility to Genetic Test. This test aims to determine the risk of developing Lewy body dementia (LBD), specifically the subtype called dementia with Lewy bodies (DLB).

Test Details

The GBA gene (glucosylceramidase beta) is associated with an increased risk of developing LBD. DLB is a neurodegenerative disorder characterized by the presence of abnormal protein aggregates called Lewy bodies in the brain.

Our test utilizes Next-generation sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes or the entire genome. It can identify variations or mutations in the GBA gene that may increase the susceptibility to developing LBD.

Components and Price

The cost of the GBA Gene Lewy Body Dementia Susceptibility to Genetic Test is 3200.0 AED. The sample condition required for the test can be either blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The report will be delivered within 3 to 4 weeks from the date of sample submission.

Test Type and Department

The GBA Gene Lewy Body Dementia Susceptibility to Genetic Test falls under the category of neurological disorders. It is conducted in our Genetics department.

Pre Test Information

Prior to undergoing the GBA Gene Lewy Body Dementia Susceptibility to Genetic Test, it is recommended to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with GBA Gene Lewy Body Dementia Susceptibility to.

Method and Doctor

The GBA Gene Lewy Body Dementia Susceptibility to Genetic Test is performed using NGS technology. Our team of experts, led by a neurologist, will handle the testing process.

Important Information

It’s important to note that genetic testing alone cannot diagnose LBD or predict the exact onset or progression of the disease. Other factors, such as environmental and lifestyle factors, also play a role in the development of LBD. Therefore, it is recommended to consult with a healthcare professional or genetic counselor before undergoing any genetic testing to understand the implications and limitations of the results.

By undergoing the GBA Gene Lewy Body Dementia Susceptibility to Genetic Test, individuals can determine if they carry any genetic variants or mutations in the GBA gene that may predispose them to LBD. This information can be useful for both individuals and healthcare providers in understanding the risk of developing LBD and implementing appropriate preventive measures or treatment plans.

Test Name GBA Gene Lewy body dementia susceptibility to Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GBA Gene Lewy body dementia, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GBA Gene Lewy body dementia, susceptibility to
Test Details

GBA gene (glucosylceramidase beta) is associated with an increased risk of developing Lewy body dementia (LBD), specifically the subtype called dementia with Lewy bodies (DLB). DLB is a neurodegenerative disorder characterized by the presence of abnormal protein aggregates called Lewy bodies in the brain.

Next-generation sequencing (NGS) is a genetic testing method that allows for the simultaneous analysis of multiple genes or the entire genome. It can be used to identify variations or mutations in the GBA gene that may increase the susceptibility to developing LBD.

By undergoing an NGS genetic test, individuals can determine if they carry any genetic variants or mutations in the GBA gene that may predispose them to LBD. This information can be useful for both individuals and healthcare providers in understanding the risk of developing LBD and implementing appropriate preventive measures or treatment plans.

It’s important to note that genetic testing alone cannot diagnose LBD or predict the exact onset or progression of the disease. Other factors, such as environmental and lifestyle factors, also play a role in the development of LBD. Therefore, it is recommended to consult with a healthcare professional or genetic counselor before undergoing any genetic testing to understand the implications and limitations of the results.

SKU: TEST-1525 Category:

Related products